Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Journal of Education, Health and Sport

Clinical and laboratory characteristics of patients with adrenal incidentalomas in the differential diagnosis of subclinical hypercortisolism
  • Home
  • /
  • Clinical and laboratory characteristics of patients with adrenal incidentalomas in the differential diagnosis of subclinical hypercortisolism
  1. Home /
  2. Archives /
  3. Vol. 10 No. 11 (2020) /
  4. Research Articles

Clinical and laboratory characteristics of patients with adrenal incidentalomas in the differential diagnosis of subclinical hypercortisolism

Authors

  • O. Tretyak Department of Neuroendocrinology and General Endocrinology of the Ukrainian Scientific and Practical Center for Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine

DOI:

https://doi.org/10.12775/JEHS.2020.10.11.023

Keywords

adrenal incidentaloma, subclinical hypercortisolism, subclinical Cushing's syndrome, autonomic cortisol secretion, primary hyperaldosteronism

Abstract

Clinical and laboratory characteristics of patients with adrenal incidentalomas in the differential diagnosis of subclinical hypercortisolism. O. E. Tretyak.

Purpose. Determination of the prevalence of subclinical Cushing's syndrome among patients with adrenal incidentalomas; determination of the diagnostic consideration of clinical and laboratory parameters used for the diagnosis of endogenous subclinical hypercortisolism.

Methods. Retrospective analysis of data from 310 patients, who underwent a surgery for unilateral/bilateral adrenal masses. A comparative analysis of the two groups was carried out; the groups were divided based on the results of postoperative pathohistological study. Group 1 included 244 patients with hormonally active masses - adenomas (210), PBMAH (31), PPNAD (3); Group 2 included 66 patients with inactive masses. There were assessed the prevalence of hypertension, DM 2, overweight and the results of laboratory studies of the cortisol level after dexamethasone suppressive test, ACTH, and daily urine-free cortisol excretion.

Results. Patients with hormonally active masses are older (mean age is 52.7 years); 68.4% of patients in group 1 haveAH, 27% haveDM2 (group 2, respectively, 36.4% and 13.6%). There are no differences between groups as to the presence of overweight and obesity. 22.5% of patients of group 1 were confirmed to havePA, in most cases against the background of bilateral masses. The parameter of cortisol after DST has the best diagnostic consideration – sensitivity 90.2%, specificity 74% at a cut-off point level of 1.7 μcg/dL; for ACTH <10 pg/mL, the sensitivity is 71.4% and the specificity is 92.6%. Daily cortisol urine-free excretion has the third most significant diagnostic consideration (sensitivity 71.4%, specificity 81.8%, COP 238 mg/24 h.), which limits the application of this parameter for the confirmation of high levels of cortisol in patients with incidentalomas. Cases of bilateral adrenal hyperplasia should be considered as a probable variant of PBMAH syndrome, requiring further laboratory testing for PA.

References

Di Dalmazi G, Vicennati V, Garelli S, Casadio E. et al Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study//Lancet Diabetes Endocrinol.- 2014 May;2(5):396-405.

Debono M., BradbumM.,BullM.Cortisol as a Marker for Increased Mortality in Patients with Incidental Adrenocortical Adenomas// J ClinEndocrinol. Metab. 2014. Vol.99(12). - P.4462-4470.

Morelli V, Scillitani A, Arosio M, ChiodiniI. Follow-up of patients with adrenal incidentaloma, in accordance with the European society of endocrinology guidelines: Could we be safe?//.J Endocrinol Invest. 2017 Mar.

Antoine Tabarin.Do the diagnostic criteria for subclinical hypercortisolism exist?//2018 Jun/79(3):146-148.

Henning Dralle, John Newell-Price, Antoine Tabarin et al. Мanagement of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors//Euro J Endocrinol. - 2016.

Hong AR, Kim JH, Park KS, Kim KY, Lee JH, Kong SH, Lee SY, Shin CS, Kim SW.Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice.//Eur J Endocrinol. 2017 Dec;177(6):475-483.

Farrugia FA, Misiakos E, Martikos G, Tzanetis P, Charalampopoulos A, Zavras N, Sotiropoulos D, KoliakosN.Rom . A step by step approach in differential diagnosing of adrenal incidentaloma (epinephroma), (with comments on the new Clinical Practice Guidelines of the European Society of Endocrinology).// J Intern Med. 2017 Dec

Choi K.M., Seu J.H., Kim Y.H., Lee E.J., Kim S.J., Bike S.H. et al. Cushing's syndrome caused by primary pigmented nodular adrenocortical disease: a case report and literature review //Korean J Intern Med.- 1995.

Shigemitsu Yasuda, Yusuke Hikima, Yusuke Kabeya, Shinichiro Iida. Clinical characterization of patients with primary aldosteronism plus subclinical Cushing's syndrome//BMC EndocrDisord 2020 Jan 13;20(1):9.

Cherenko S.M., Tretyak O.E., Tovkai O.A. Adrenokorticotropin-independent macronodular adrenal hyperplasia: the first clinical experience in Ukraine//Clinical endocrinology and endocrine surge. 2016 .2 (54) . S. 85-93.

Araujo-Castro M, SampedroNúñez MA, Marazuela M. Autonomous cortisol secretion in adrenal incidentalomas. Endocrine. 2019 Apr;64(1):1-13.

Downloads

  • PDF

Published

2020-11-30

How to Cite

1.
TRETYAK, O. Clinical and laboratory characteristics of patients with adrenal incidentalomas in the differential diagnosis of subclinical hypercortisolism. Journal of Education, Health and Sport [online]. 30 November 2020, T. 10, nr 11, s. 238–244. [accessed 30.3.2023]. DOI 10.12775/JEHS.2020.10.11.023.
  • PN-ISO 690 (Polish)
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 10 No. 11 (2020)

Section

Research Articles

License

The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0

Stats

Number of views and downloads: 215
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

adrenal incidentaloma, subclinical hypercortisolism, subclinical Cushing's syndrome, autonomic cortisol secretion, primary hyperaldosteronism
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Karmelitański Instytut Duchowości w Krakowie
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop